Skip to main content

Articles

Page 3 of 7

  1. Hypertension is the most prevalent cardiovascular disease in Zimbabwe. The prevalence of Hypertension in the country is above 30% regardless of the cut off used. Currently, majority of patients in Zimbabwe see...

    Authors: Victor Basopo and Paschal N. Mujasi

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:37

    Content type: Research

    Published on:

  2. Evaluating outcomes after tuberculosis (TB) treatment can help identify the primary reasons for treatment success or failure. However, Yemen has a treatment success rate that remains below the World Health Org...

    Authors: Ammar Ali Saleh Jaber, Amer Hayat Khan and Syed Azhar Syed Sulaiman

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:36

    Content type: Research

    Published on:

  3. Uganda was one of seven countries in which the United Nations Commission on Life Saving Commodities (UNCoLSC) initiative was implemented starting from 2013. A nationwide survey was conducted in 2015 to determi...

    Authors: Denis Kibira, Freddy Eric Kitutu, Gemma Buckland Merrett and Aukje K. Mantel-Teeuwisse

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:35

    Content type: Research

    Published on:

  4. Community pharmacists are very accessible to most patients yet; they have been underutilized in the aspect of providing HIV care and services. The World Health Organisation recently recommended expanding commu...

    Authors: Nnenna Ajagu, Maureen Ugonwa Anetoh and Sunday Odunke Nduka

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:34

    Content type: Research

    Published on:

  5. Supportive supervision has been found to be more effective than corrective fault-oriented inspections. Uganda’s Ministry of Health in 2012 implemented a comprehensive strategy (SPARS) to build medicines manage...

    Authors: Rachael Henry, Lynda Nantongo, Anita Katharina Wagner, Martha Embrey and Birna Trap

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:33

    Content type: Research

    Published on:

  6. The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and re...

    Authors: Fawz Kazzazi, Cleo Pollard, Paul Tern, Alejandro Ayuso-Garcia, Jack Gillespie and Inesa Thomsen

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:32

    Content type: Review

    Published on:

  7. High drug spending is a concern for policy makers due to limits on access for patients. Numerous policies have been proposed to address high drug spending. The existence of multifarious proposals makes it diff...

    Authors: Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar and Gerard Anderson

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:31

    Content type: Research

    Published on:

  8. Despite making great progress in reducing under five mortality in the last three decades. Uganda still ranks high among countries with the highest under five mortality rates. More than a third (36%) of these d...

    Authors: Lorraine Nabbanja Kabunga and Paschal Mujasi

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:30

    Content type: Research

    Published on:

  9. Opioids are widely prescribed for chronic non cancer pain (CNCP). Controlled substance agreements (CSAs) are intended to increase adherence and mitigate risk with opioid prescribing. We evaluated the demograp...

    Authors: Lindsey M. Philpot, Priya Ramar, Muhamad Y. Elrashidi, Raphael Mwangi, Frederick North and Jon O. Ebbert

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:29

    Content type: Research

    Published on:

  10. Different methods in pharmacoepidemiology can be used to study hypnotic use in children. But neither questionnaire-based data nor prescription records can be considered a “gold standard”. This study aimed to i...

    Authors: Ingvild Holdø, Jørgen G. Bramness, Marte Handal, Leila Torgersen, Ted Reichborn-Kjennerud, Eivind Ystrøm, Hedvig Nordeng and Svetlana Skurtveit

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:28

    Content type: Research

    Published on:

  11. Authors: Isha Patel, Rabia Hussain, Anam Khan, Akram Ahmad, Muhammad Umair Khan and Mohamed Azmi Ahmed Hassalai

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:27

    Content type: Letter to the Editor

    Published on:

  12. The importance of creating and sustaining a strong culture of patient safety has been recognized as a critical component of safe medication use. This study aims to assess changes in attitudes toward patient sa...

    Authors: Chanadda Chinthammit, Michael T. Rupp, Edward P. Armstrong, Tara Modisett, Rebecca P. Snead and Terri L. Warholak

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:26

    Content type: Research

    Published on:

  13. Prescribing errors at the time of hospital discharge are common and could potentially lead to avoidable patient harm, especially when they involve insulin, a high-risk medicine widely used for the treatment of...

    Authors: Amie Bain, Lois Nettleship, Sallianne Kavanagh and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:25

    Content type: Research

    Published on:

  14. Babies are increasingly being exposed to antibiotics intrapartum in the bid to reduce neonatal and maternal deaths. Intrapartum antibiotic exposure, including even those considered safe in pregnancy, have been...

    Authors: Kwesi Boadu Mensah, Kwame Opoku-Agyeman and Charles Ansah

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:24

    Content type: Research

    Published on:

  15. Reports from drug utilization reviews are important tools employed in the assessment of healthcare practices. The objective of this study was to evaluate drug utilization patterns among elderly hospitalized pa...

    Authors: Muhammad Rehan Sarwar, Muhammad Atif, Shane Scahill, Anum Saqib, Muhammad Qamar-uz-Zaman and Zaheer Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:23

    Content type: Research

    Published on:

  16. Despite pharmaceutical sciences being a core component of pharmacy curricula, few published studies have focussed on innovative methodologies to teach the content. This commentary identifies imaging techniques...

    Authors: Louise E. Curley, Julia Kennedy, Jordan Hinton, Ali Mirjalili and Darren Svirskis

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:22

    Content type: Commentary

    Published on:

  17. The private retail drug shops market in Bangladesh is largely unregulated and unaccountable, giving rise to irrational use of drugs and high Out-of-pocket expenditure on health. These shops are served by sales...

    Authors: Syed Masud Ahmed, Nahitun Naher, Tarek Hossain and Lal Bahadur Rawal

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:21

    Content type: Research

    Published on:

  18. Smoking is the number one cause of preventable morbidity and mortality globally and although many countries have invested heavily in smoking cessation programs, 21% of the global population still smoke. Post c...

    Authors: Raewyn Rees and Ali Seyfoddin

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:20

    Content type: Review

    Published on:

  19. The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agree...

    Authors: Ellen F. M. ‘t Hoen, Pascale Boulet and Brook K. Baker

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:19

    Content type: Review

    Published on:

  20. Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing ...

    Authors: Taryn Vian, Jillian C. Kohler, Gilles Forte and Deirdre Dimancesco

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:18

    Content type: Research

    Published on:

  21. Many middle-income countries are scaling up health insurance schemes to provide financial protection and access to affordable medicines to poor and uninsured populations. Although there is a wealth of evidence...

    Authors: Warren A. Kaplan, Paul G. Ashigbie, Mohamad I. Brooks and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:17

    Content type: Research

    Published on:

  22. Medicines use related challenges such as inadequate adherence, high levels of antimicrobial resistance and preventable adverse drug reactions have underscored the need to incorporate pharmaceutical services to...

    Authors: Niranjan Konduri, Megan Rauscher, Shiou-Chu Judy Wang and Tanya Malpica-Llanos

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:16

    Content type: Research

    Published on:

  23. The Affordable Medicines Facility for malaria (AMFm) Program was a subsidy aimed at artemisinin-based combination therapies (ACTs) in order to increase availability, affordability, and market share of ACTs in ...

    Authors: Alexander Freeman, Anthony Kwarteng, Lawrence Gyabaa Febir, Seeba Amenga-Etego, Seth Owusu-Agyei and Kwaku Poku Asante

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:15

    Content type: Research

    Published on:

  24. The purpose of this study is to explore medication-related perceptions of adult patients with type 2 diabetes attending treatment in public hospitals of urban centers in central Ethiopia.

    Authors: Bruck Messele Habte, Tedla Kebede, Teferi Gedif Fenta and Heather Boon

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:14

    Content type: Research

    Published on:

  25. The inappropriate use of antimicrobials is a problem worldwide. To target future interventions, a thorough understanding of the reasons behind this current behaviour is needed. Within the EU, the culture of an...

    Authors: Susanne Kaae, Admir Malaj and Iris Hoxha

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:13

    Content type: Research

    Published on:

  26. This article aims to highlight the positions of the Food and Drug Administration and the European Medicines Agency regarding use and marketing of hydroxyethyl starch (HES) products, and how these have changed ...

    Authors: Christian J. Wiedermann and Klaus Eisendle

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:12

    Content type: Policy analysis

    Published on:

  27. It is essential to allocate available resources equitably in order to ensure accessibility and affordability of essential medicines, especially in less fortunate nations with limited health funding. Currently,...

    Authors: Gereltuya Dorj, Bruce Sunderland, Tsetsegmaa Sanjjav, Gantuya Dorj and Byambatsogt Gendenragchaa

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:11

    Content type: Policy Analysis

    Published on:

  28. When patients are told that standard medical treatment options have been exhausted, their treating physicians may start looking for promising new drugs that are not yet approved, and still under investigation....

    Authors: Eline M. Bunnik, Nikkie Aarts and Suzanne van de Vathorst

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:10

    Content type: Commentary

    Published on:

  29. Lack of regulatory capacity limits the conduct of ethical and rigorous trials of herbal medicines in developing countries. Sharing ethical and regulatory experiences of successful herbal trials may accelerate ...

    Authors: Tsitsi G. Monera-Penduka, Charles C. Maponga, Gene D. Morse and Charles F. B. Nhachi

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:9

    Content type: Research

    Published on:

  30. Asthma as a chronic health condition can be controlled when in addition to clinical care, adequate education and support is provided to enhance self-management. Like many other chronic health conditions improv...

    Authors: Philip O. Anum, Berko P. Anto and Audrey G. Forson

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:8

    Content type: Research

    Published on:

  31. Private-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perf...

    Authors: Niranjan Konduri, Emily Delmotte and Edmund Rutta

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:6

    Content type: Research

    Published on:

  32. The Medicines Transparency Alliance (MeTA) is an initiative that brings together all stakeholders in the medicines market to create a multi-stakeholder dialogue and improve access, availability and affordabili...

    Authors: Gemma L. Buckland-Merrett, Catherine Kilkenny and Tim Reed

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:5

    Content type: Research

    Published on:

  33. The WHO Model List of Essential Medicines for Children (EMLc) covers medicines for globally high-burden diseases. Regulatory approval in high-income countries ensures evidence and dosage form but usually focus...

    Authors: Rumiko Shimazawa and Masayuki Ikeda

    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:4

    Content type: Research

    Published on:

  34. This study aims at identifying predictors of the treatment decision of German physicians with regard to a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted protease inhibitor (PI/r)...

    Authors: Jörg Mahlich, Mona Groß, Alexander Kuhlmann, Johannes Bogner, Hans Heiken and Matthias Stoll

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:39

    Content type: Research

    Published on:

  35. There is substantial evidence of poor dispensing practices with inadequate packaging and labelling of medicines, and limited advice on their usage in low and middle-income countries (LMICs). We examined the la...

    Authors: N. Athuraliya, E. J. Walkom, S. Dharmaratne and J. Robertson

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:38

    Content type: Research

    Published on:

  36. It has been proven that the interaction between pharmaceutical representatives and physicians can directly influence the latter’s prescribing behaviour. This meta-synthesis aims to explore the available studie...

    Authors: Shahrzad Salmasi, Long Chiau Ming and Tahir Mehmood Khan

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:37

    Content type: Review

    Published on:

  37. The globalization of pharmaceutical production has not been accompanied by a strengthening and harmonization of the regulatory systems worldwide. Thus, the global market is characterized today by a situation o...

    Authors: Raffaella Ravinetto, Daniel Vandenbergh, Cécile Macé, Corinne Pouget, Brigitte Renchon, Jean Rigal, Benedetta Schiavetti and Jean-Michel Caudron

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:36

    Content type: Commentary

    Published on:

  38. High oral bioavailability of antimicrobial agents can result in the replacement of intravenous (IV) therapy with oral therapy when a patient meets defined clinical criteria. However, few studies have evaluated...

    Authors: Akihiro Tanaka, Akiko Yano, Shinichi Watanabe, Mamoru Tanaka and Hiroaki Araki

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:35

    Content type: Short Report

    Published on:

  39. The increasing threat of antimicrobial resistance combined with the paucity of new classes of antibiotics represents a serious public health challenge. New treatment technologies could, in theory, have a signi...

    Authors: Ejike Nwokoro, Ross Leach, Christine Årdal, Enrico Baraldi, Kellie Ryan and Jens Plahte

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:34

    Content type: Research

    Published on:

  40. Annual immunization is the most effective way to prevent influenza and its associated complications. However, optimal immunization rates are not being met in Nova Scotia, Canada. Additional providers, such as ...

    Authors: Jennifer E. Isenor, Jessica L. Killen, Beverly A. Billard, Shelly A. McNeil, Donna MacDougall, Beth A. Halperin, Kathryn L. Slayter and Susan K. Bowles

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:32

    Content type: Research

    Published on:

  41. The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-makers, who need to oversee the transformation of health systems that evolved to provide easy access to these drugs in...

    Authors: Gemma L. Buckland Merrett, Gerald Bloom, Annie Wilkinson and Hayley MacGregor

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:31

    Content type: Review

    Published on:

  42. Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation ...

    Authors: Rasmus Borup, Susanne Kaae, Timo Minssen and Janine Traulsen

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:30

    Content type: Research

    Published on:

  43. The rising demand for chronic disease treatment and the barriers to accessing these medicines have led to the development of novel models for distributing medicines in South Africa’s public sector, including d...

    Authors: Bvudzai Priscilla Magadzire, Bruno Marchal and Kim Ward

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:28

    Content type: Research

    Published on:

  44. Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments...

    Authors: Louise E. Curley, Janice Moody, Rukshar Gobarani, Trudi Aspden, Maree Jensen, Maureen McDonald, John Shaw and Janie Sheridan

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:29

    Content type: Review

    Published on:

  45. Medicines are a main therapeutic intervention provided within hospitals and their proper use in the outpatient setting is important for patients and the community. The objective of this study was to evaluate d...

    Authors: Muhammad Atif, Muhammad Rehan Sarwar, Muhammad Azeem, Danial Umer, Abdul Rauf, Arslan Rasool, Muhammad Ahsan and Shane Scahill

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:27

    Content type: Research

    Published on:

  46. The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limi...

    Authors: Chia-Ying Lee, Xiaohan Chen, Robert J. Romanelli and Jodi B. Segal

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:26

    Content type: Review

    Published on:

  47. The proposed Pharmacy Bill of Malaysia which served to consolidate and harmonise the existing pharmacy legislation which has been used for more than 60 years. This new Pharmacy Bill contains 17 parts and a tot...

    Authors: Kah Seng Lee, Yen Wei Lim and Long Chiau Ming

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:25

    Content type: Commentary

    Published on:

  48. Providing patient-centred care requires pharmacy students to learn how to interact effectively and understand individual differences that can influence patients’ health. The School of Pharmacy at The University o...

    Authors: Louise E. Curley, Maureen McDonald and Trudi Aspden

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:24

    Content type: Research

    Published on:

Annual Journal Metrics